Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00062621 · ClinicalTrials.gov registry record · Phase 1
Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
A Phase 1 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT00062621 is a Phase 1 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 5 participants.
The verdict
NCT00062621, a Phase 1 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a combined bone marrow and kidney transplant will be effective in treating stage II or greater multiple myeloma and associated kidney failure. This study will determine whether transplant rejection and the need for immunosuppressive drugs are decreased with this combined transplant approach.
Interventions
- PROCEDURE Combined bone marrow and kidney transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2003-06 |
| Est. Completion | 2006-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00062621
The ClinicalTrials.gov registry entry for NCT00062621 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Combined bone marrow and kidney transplant is the first listed.
NCT00062621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00062621 about?
NCT00062621 is a clinical study titled "Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure". The purpose of this study is to determine whether a combined bone marrow and kidney transplant will be effective in treating stage II or greater multiple myeloma and associated kidney failure. This study will determine whether transplant rejection and the need for immunosuppressive drugs are decreas...
What is the current status of trial NCT00062621?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2003-06. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00062621?
The interventions under investigation include: Combined bone marrow and kidney transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00062621?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.